Tumour-suppressive function of SIRT4 in human colorectal cancer
暂无分享,去创建一个
H. Ishii | Y. Doki | N. Nishida | I. Takemasa | T. Mizushima | M. Konno | J. Koseki | K. Kawamoto | Hirofumi Yamamoto | M. Mori | M. Uemura | H. Ogawa | J. Nishimura | M. Uemura | Y Doki | M Uemura | I Takemasa | T. Hata | M Miyo | H Yamamoto | M Konno | H Colvin | N Nishida | J Koseki | K Kawamoto | H Ogawa | A Hamabe | J Nishimura | T Hata | T Mizushima | M Mori | H Ishii | A. Hamabe | Tsuyoshi Hata | M. Miyo | H. Colvin | H. Yamamoto | Masaki Mori | N. Nishida | Hugh Colvin | Jun Koseki | Hisataka Ogawa
[1] R. Deberardinis,et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.
[2] C. Dang,et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. , 2010, Cancer cell.
[3] R. Poulsom,et al. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. , 1995, British Journal of Cancer.
[4] S. Gygi,et al. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. , 2012, Molecular cell.
[5] W. Che,et al. SIRT4 Prevents Hypoxia-Induced Apoptosis in H9c2 Cardiomyoblast Cells , 2013, Cellular Physiology and Biochemistry.
[6] F. Alt,et al. SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells , 2006, Cell.
[7] Xing Fu,et al. Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling , 2005, Clinical & Experimental Metastasis.
[8] Ying Yuan,et al. Secreted Protein Acidic and Rich in Cysteines-like 1 Suppresses Aggressiveness and Predicts Better Survival in Colorectal Cancers , 2012, Clinical Cancer Research.
[9] Lynette M. Smith,et al. Activated KrasG12D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin , 2011, British Journal of Cancer.
[10] Gregory Stephanopoulos,et al. The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4 , 2013, Cell.
[11] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[12] T. Dønnem,et al. The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer , 2008, British Journal of Cancer.
[13] Z. Yi,et al. Positive Expression of LSD1 and Negative Expression of E-cadherin Correlate with Metastasis and Poor Prognosis of Colon Cancer , 2013, Digestive Diseases and Sciences.
[14] Xiaoling Xu,et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. , 2013, Cancer cell.
[15] S. Voelter-Mahlknecht,et al. Fluorescence in situ hybridization and chromosomal organization of the sirtuin 4 gene (Sirt4) in the mouse. , 2009, Biochemical and biophysical research communications.
[16] X. Zuo,et al. Milk Fat Globule-Epidermal Growth Factor 8 Is Decreased in Intestinal Epithelium of Ulcerative Colitis Patients and Thereby Causes Increased Apoptosis and Impaired Wound Healing , 2012, Molecular medicine.
[17] K. Mimori,et al. Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial–mesenchymal transition , 2014, Proceedings of the National Academy of Sciences.
[18] Liang Han,et al. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells. , 2013, Current medicinal chemistry.
[19] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[20] Frank Speleman,et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.
[21] M. Welliver,et al. The B55α subunit of PP2A drives a p53-dependent metabolic adaptation to glutamine deprivation. , 2013, Molecular cell.